Frontier Capital Management, an investment management company, released its “Frontier Small Cap Growth Fund” first quarter ...

Personalis and Tempus AI are adding colorectal cancer as a new indication to their existing commercialization agreement.

Tempus AI will collaborate with Northwestern University's neurogenomics researchers to use artificial intelligence to accelerate discovery of treatments for Alzheimer's disease, the Chicago-based ...

Veteran analyst unveils bold price target for Tempus AI stock originally appeared on TheStreet. While much of Wall Street is focused on AI chipmakers and cloud giants, one AI health care stock is ...

The lawsuit stems from last month's report that claimed Tempus overstates its AI capabilities and engages in "aggressive accounting." ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of its care pathway intelligence platform, ...

Tempus AI TEM is entering a phase of strong operating momentum, backed by significant acceleration in both revenues and gross ...

In an exciting development for Tempus AI (NasdaqGS:TEM), the company experienced a significant 51% increase in its share price over the last quarter. This surge coincides with major events ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in TD Cowen's ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in TD Cowen's/Securities' 4th Annual Tools/Dx ...